comparemela.com
Latest Breaking News On - Analyst sees durable share gains - Page 1 : comparemela.com
Medtech Firm Enovis Sets Strong 2024 Targets As Q4 Earnings Beat Expectations, Analyst Says Growth Intact - Enovis (NYSE:ENOV)
Enovis reports Q4 results with net sales surging 11% YoY, reaching $455 million. The growth is attributed to strong performance in P&R and above-market expansion in Recon, coupled with recent acquisitions impact.
Lima
Peru
Matt-trerotola
William-blair
Enovis-corporation
Analyst-sees-durable-share-gains
Margin-expansion-for-orthopedics-focused
Chief-executive-officer
vimarsana © 2020. All Rights Reserved.